Stem cells in amyotrophic lateral sclerosis: State of the art

Expert Opinion on Biological Therapy

Volumn 9, Issue 10, 2009, Pages 1245-1258

  Mazzini, Letizia ^a   Vercelli, Alessandro ^b   Ferrero, Ivana ^b   Mareschi, Katia ^b   Boido, Marina ^b   Servo, Serena ^a   Oggioni, Gaia Donata ^a   Testa, Lucia ^a   Monaco, Francesco ^a   Fagioli, Franca ^c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Animal models; Cell therapy; Stem cells

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ADULT STEM CELL; AMYOTROPHIC LATERAL SCLEROSIS; CELL SURVIVAL; CLINICAL TRIAL; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTONEURON; MUSCLE FUNCTION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PRACTICE GUIDELINE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MOTOR NEURONS; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 70349389656     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590903186956     Document Type: Review

References (117)

1. Kanazawa I. How do neurons die in neurodegenerative diseases? Trends Mol Med 2001;7(8):339-344
2. Bradley WG. Updates on amyotrophic lateral sclerosis: improving patient care. Ann Neurol 2009;65(1):S1-2
3. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65(l):S3-9
4. Brooks BR. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life. Ann Neurol 2009;65(1):S17-23
5. Lee ST, Chu K, Jung KH, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008;131(Pt 3):616-629 (Pubitemid 351294711)
6. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-736
7. Ben-Hur T. Immunomodulation by neural stem cells. J Neurol Sci 2008;265:102-104
8. Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009;27:1050-1056
9. Thonhoff JR, Jordan PM, Karam JR, et al. Identification of early disease progression in an ALS rat model. Neurosci Lett 2007;415(3):264-268 (Pubitemid 46400265)
10. De Carvalho M, Costa J, Swash M. Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6(4):202-212 (Pubitemid 43123550)
11. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147
12. Brazelton TR, Rossi FMV, Keshet GI, et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000;290:1775-1779 (Pubitemid 32004810)
13. Valliéres L, Sawchenko PE. Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 2003;23:5197-5207 (Pubitemid 36793248)
14. Castro RF, Jackson KA, Goodell MA, et al. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002;297:1299 (Pubitemid 34913161)
15. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell 2000;100:143-155 (Pubitemid 30046303)
16. Choumerianou DM, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev 2008;14:53-60
17. Aejaz HM, Aleem AK, Parveen N, et al. Stem cell therapy-present status. Transplant Proc 2007;39:694-699
18. Henningson CT Jr, Stanislaus MA, Gewirtz AM, etal. Embryonic and adult stem cells therapy. J Allergy Clin Immunol 2003;111:S745-53
19. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676 (Pubitemid 44233629)
20. Chandran S. What are the prospects of stem cell therapy for neurology? BMJ 2008;337:a1934
21. Li XJ, Du ZW, Zarnowska ED, et al. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 2005;23:215-221 (Pubitemid 40255332)
22. Di Giorgio FP, Carrasco MA, Siao MC, et al. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007;10:608-614
23. Karumbayaram S, Kelly TK, Paucar AA, et al. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis Model Mech 2009;2(3-4):189-195
24. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 2008;3(6):637-648
25. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49 (Pubitemid 46865811)
26. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can generate motor neurons. Science 2008;321:1218-1221
27. Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008;9(9):725-729
28. Crigler L, Robey RC, Asawachaicharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006;198:54-64 (Pubitemid 43243744)
29. Vercelli A, Mereuta OM, Garbossa D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008;31(3):395-405
30. Suzuki M, Svendsen CN. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci 2008;31(4):192-198
31. Gordon D, Scolding NJ. Human mesenchymal stem cell culture for neural transplantation. Methods Mol Biol 2009;549:103-118
32. Aiba K, Sharov A, Carter M, et al. Mouse embryonic stem cells and adult neural stem/progenitor cells defining a developmental path to neural fate by global expression profiling of mouse embryonic stem cells and adult neural stem/progenitor cells. Stem Cells 2006;24;889-895
33. Lladò J, Haenggeli C, Maragakis NJ, et al. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 2004;27(3):322-331 (Pubitemid 39433844)
34. Lepore AC, Rauck B, Dejea C, et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 2008;11(11):1294-1301
35. Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006;7(5):395-406
36. Tsyb AF, Yuzhakov VV, Roshal' LM, et al. Morphofunctional study of the therapeutic efficacy of human mesenchymal and neural stem cells in rats with diffuse brain injury. Bull Exp Biol Med 2009;147(1):132-146
37. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992;140(3):691-707
38. Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci 2000;67(1):53-59 (Pubitemid 30368622)
39. Garbuzova-Davis S, Willing AE, Zigova T, et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. Hematother Stem Cell Res 2003;12(3):255-270 (Pubitemid 36736737)
40. Mareschi K, Novara M, Rustichelli D, et al. Neural differentiation of human mesenchymal stem cells: evidence for expression of neural markers and eag K+ channel types. Exp Hematol 2006;34:1563-1572 (Pubitemid 44566419)
41. Ferrero I, Mazzini L, Rustichelli D, et al. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant 2008;17(3):255-266 (Pubitemid 351717329)
42. Yan J, Xu L, Welsh A, et al. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 2006;24:1976-1985 (Pubitemid 44474174)
43. Xu L, Ryugo DK, Pongstaporn T, et al. Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry. J Comp Neurol 2009;514:297-299
44. Corti S, Locatelli F, Papadimitriou D, et al. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 2007;130(Pt 5):1289-1305 (Pubitemid 47355948)
45. Hedlund E, Hefferan MP, Marsala M, Isacson O. Cell therapy and stem cells in animal models of motor neuron disorders. Eur J Neurosci 2007;26:1721-1737 (Pubitemid 47493182)
46. De Hemptinne I, Boucherie C, Pochet R, et al. Unilateral induction of progenitors in the spinal cord of hSOD1G93A transgenic rats correlates with an asymmetrical hind limb paralysis. Neurosci Lett 2006;401:25-29
47. Liu Z, Martin LJ. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain. J Comp Neurol 2006;497:468-488 (Pubitemid 43865797)
48. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005;19:1129-1155 (Pubitemid 40696181)
49. Deshpande DM, Kim YS, Martinez T, et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006;60:32-44
50. Vogel G. Cell biology. Ready or not? Human ES cells head toward the clinic. Science 2005;308:1534-1538
51. Galli R, Gritti A, Bonfanti L, Vescovi L. Neural stem cells: an overview. Circ Res 2003;92:598-608
52. Emgärd M, Holmberg L, Samuelsson EB, et al. Human neural precursor cells continue to proliferate and exhibit low cell death after transplantation to the injured rat spinal cord. Brain Res 2009;30(1278):15-26
53. Capowski EE, Schneider BL, Ebert AD, et al. Lentiviral vector-mediated genetic modification of human neural progenitor cells for exvivo gene therapy. J Neurosci Methods 2007;30:163(2):338-349
54. Klein SM, Behrstock S, McHugh J, et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005;16(4):509-521 (Pubitemid 40647148)
55. Suzuki M, McHugh J, Tork C, et al. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2007;2(1):e689, published online 1 August 2007 doi:10.1371/journal.pone.0000689 (Pubitemid 351325410)
56. Garbuzova-Davis S, Willing AE, Milliken M, et al. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp Neurol 2002;174(2):169-180 (Pubitemid 34293447)
57. Neusch C, Bähr M, Schneider-Gold C. Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve 2007;35(6):712-724
58. Van Den Bosch L, Robberecht W. Crosstalk between astrocytes and motor neurons: what is the message? Exp Neurol 2008;211(1):1-6
59. Huard J, Youngento B, Goldstein B, et al. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. J Comp Neurol 1998;400:469-486 (Pubitemid 28455623)
60. Richter MW, Roskams AJ. Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope? Exp Neurol 2008;209:353-367
61. Garbuzova-Davis S, Sanberg PR. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp Neurol 2009;216(1):3-6
62. Bonilla S, Silva A, Geijo E, et al. Functional neural stem cells derived from adult bone marrow. Neuroscience 2005;133:85-95 (Pubitemid 40694160)
63. Moraleda JM, Blanquer M, Bleda P, et al. Adult stem cell therapy: dream or reality? Transpl Immunol 2006;17:74-77
64. Beers DR, Henkel JS, Zhao W, et al. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci USA 2008;105(40):1558-1563
65. Rice CM, Scolding NJ. Adult stem cells for the treatment of neurological disease. Methods Mol Biol 2009;549:17-32
66. Chen Y, Shao JZ, Xiang LX, et al. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol 2008;40(5):815-820
67. Garbuzova-Davis S, Willing AE, Saporta S, et al. Novel cell therapy approaches for brain repair. Prog Brain Res 2006;157:207-222 (Pubitemid 44566489)
68. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317
69. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007;25(11):2896-2902
70. Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:364-370 (Pubitemid 30620221)
71. Deng W, Obrocka M, Fischer I, et al. Invitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 2001;282:148-152 (Pubitemid 32924357)
72. Kohyama J, Abe H, Shimazaki T. Brain from bone: efficient metadifferentiation of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation 2001;68:235-244 (Pubitemid 33754996)
73. Kim BJ, Seo JH, Bubien JK, et al. Differentiation of adult bone marrow stem cells into neuroprogenitor cells invitro. Neuroreport 2002;13:1185-1188 (Pubitemid 34722050)
74. Muñoz-Elìas G, Woodbury D, Black IB. Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells 2003;21:437-448 (Pubitemid 36793486)
75. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells invitro. Exp Neurol 2000;164:247-256 (Pubitemid 32008970)
76. Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 2004;77:174-191 (Pubitemid 38859403)
77. Bertani N, Malatesta P, Volpi G, et al. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. J Cell Sci 2005;118:3925-3936 (Pubitemid 41410276)
78. Kim J, Kang JW, Park JH, etal. Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res 2009;32(1):117-126
79. Minguell JJ, Fierro FA, Epunan MJ, et al. Nonstimulated human uncommitted mesenchymal stem cells express cell markers of mesenchymal and neural lineages. Stem Cells Dev 2005;14:408-414 (Pubitemid 41243704)
80. Blondheim NR, Levy YS, Ben-Zur T, et al. Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev 2006;15:141-164 (Pubitemid 43726495)
81. Rice CM, Scolding NJ. Adult stem cells-reprogramming neurological repair? Lancet 2004;364(9429):193-199
82. Abdi R, Fiorina P, Adra CN, et al. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type1 diabetes. Diabetes 2008;57(7):1759-1767
83. Uccelli A, Zappia E, Benvenuto F, et al. Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opin Biol Ther 2006;6:17-22 (Pubitemid 43049343)
84. Borchelt DR. Amyotrophic lateral sclerosis-are microglia killing motor neurons? N Engl J Med 2005;55:1611-1613
85. Feeney SJ, McKelvie PA, Austin L, et al. Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2001;24:1510-1519 (Pubitemid 32995587)
86. Christou YA, Moore HD, Shaw PJ, et al. Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neuron disease. Neuropathol Appl Neurobiol 2007;33:485-498
87. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084 (Pubitemid 44128350)
88. Hamada H, Kobune M, Nakamura K, et al. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 2005;96:149-156 (Pubitemid 40575915)
89. Zwart I, Hill AJ, Al-Allaf F, etal. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Exp Neurol 2009;216(2):439-448
90. Liu H, Honmou O, Harada K, et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006;129:2734-2745 (Pubitemid 44522106)
91. McMahon JM, Conroy S, Lyons M, et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 2006;15:87-96
92. Suzuki M, McHugh J, Tork C, et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 2008;16(12):2002-2010
93. Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term invitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67(19):9142-9149 (Pubitemid 47535900)
94. Choumerianou DM, Dimitriou H, Perdikogianni C, etal. Study of oncogenic transformation in exvivo expanded mesenchymal cells, from paediatric bone marrow. Cell Prolif 2008;41(6):909-922
95. Zhong Z, Deane R, Ali Z, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 2008;11:420-422
96. Garbuzova-Davis S, Haller E, Saporta S, et al. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 2007;1157:126-137 (Pubitemid 46935078)
97. Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, etal. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE 2008;3(6):e2494, published online 25 June 2008, doi:10.1371/journal.pone. 0002494
98. Corti S, Locatelli F, Donadoni C, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004;127:2518-2532 (Pubitemid 39472980)
99. Corti S, Locatelli F, Papadimitriou D, et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet 2006;15(2):167-187 (Pubitemid 43125973)
100. Habisch HJ, Janowski M, Binder D, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm 2007;114(11):1395-1406 (Pubitemid 350112275)
101. Morita E, Watanabe Y, Ishimoto M, et al. A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol 2008;213(2):431-438
102. Janson CG, Ramesh TM, During MJ, et al. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic Lateral Sclerosis. J Hemat Stem Cell Res 2001;10:913-915
103. Garbuzova-Davis S, Willing AE, Milliken M, et al. Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:175-180 (Pubitemid 34498538)
104. Hemendinger R, Wang J, Malik S, et al. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Exp Neurol 2005;196:235-243 (Pubitemid 41607811)
105. Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007;10:615-622 (Pubitemid 46652435)
106. Riley J, Butler J, Baker KB, et al. Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation. Stereotact Funct Neurosurg 2008;86(2):67-74 (Pubitemid 351341531)
107. Dobrowolny G, Aucello M, Rizzuto E, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 2008;8(5):425-436
108. Guillot S, Azzouz M, Dèglon N, et al. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1G93A transgenic mice. Neurobiol Dis 2004;16:139-149 (Pubitemid 38569805)
109. Mohajeri MH, Figlewicz DA, Bohn MC. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther 1999;10(11):1853-1866
110. Guidelines for the Clinical Translation of Stem Cells. Deerfield, Illinois, International Society for Stem Cell Research, 2008. Available from: http://www.isscr.org/clinical-trans/. [Last accessed 31 July 2009]
111. Mazzini L, Mareschi K, Ferrero I, et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 2008;265:78-83
112. Cashman N, Tan LY, Krieger C, et al. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve 2008;37:620-625
113. Appel SH, Engelhardt JI, Henkel JS. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008;71:1326-1334
114. Deda H, Inci MC, Kürekĉi AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009;11(1):18-22
115. Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, etal. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009;11(1):26-34
116. Xu L, Yan J, Chen D, etal. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006;82:865-875
117. Boucherie C, Schäfer S, Lavand'homme P, et al. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res 2009;87(9):2034-2046